The novel treatment of the medication represents a major breakthrough in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide impacts dual pathways – the GLP-1 hormone and the GIP hormone – providing enhanced sugar control and potential weight reduction. Exper